Sort
130,381 grants matching “hiv”
Next Generation HSC Gene Therapy for HIV Control and Eradication
$2,514,507Paula M Cannon · University Of Southern California · U19 · FY2017 · HL
Next Generation HSC Gene Therapy for HIV Control and Eradication
$2,514,507Paula M Cannon · University Of Southern California · U19 · FY2016 · HL
Immunologic And Virologic Approaches To HIV-1 Therapeutics
$2,513,865Richard Davey · Niaid Extramural Activities · Z01 · FY2007 · AI
Center for AIDS Research at Emory University
$2,513,855Carlos Del Rio · Emory University · P30 · FY2016 · AI
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, Zika and Japanese Encephalitis Virus vaccines
$2,513,447Jay Nelson · Oregon Health & Science University · N01 · FY2017 · AI
Excess cardiovascular inflammation in TB and HIV: EXFIN-TB
$2,513,201Gregory P. Bisson · University Of Pennsylvania · R01 · FY2025 · HL
Emory WIHS CRS - Longitudinal Cohort
$2,512,902Ighovwerha Ofotokun · Emory University · U01 · FY2017 · AI
PS10-1001, HIV PREVENTION PROJECTS
$2,512,653Jan Fox · Oklahoma State Department Of Health · U62 · FY2010 · PS
Immune Network Dysregulation of the Central Nervous System with HIV Persistence and Opioid Abuse
$2,512,500Le Zhang · Yale University · DP2 · FY2022 · DA
Novel, Adaptive Approaches to Predicting and Responding to Outbreaks of Overdose, HIV and HCV Among People Who Use Drugs
$2,512,500Gregg Steven Gonsalves · Yale University · DP2 · FY2019 · DA
Network-based epidemiology for hidden and hard-to-reach populations
$2,512,500Forrest Wrenn Crawford · Yale University · DP2 · FY2016 · HD
PS04-012, HIV PREVENTION PROJECTS
$2,511,633Jan M Fox · Oklahoma State Department Of Health · U62 · FY2009 · PS
Center/Coordination, Analysis and Management/MACS
$2,510,945Lisa P Jacobson · Johns Hopkins University · U01 · FY2009 · AI
Center for the Analysis & Management of the Multicenter AIDS Cohort Study
$2,510,945Lisa P Jacobson · Johns Hopkins University · U01 · FY2009 · AI
Limited interaction cohort to identify determinants of viral suppression in MSM and transfeminine individuals living with HIV: A multilevel approach
$2,510,861Patrick Sean Sullivan · Emory University · UG3 · FY2023 · AI
Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling
$2,510,147Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
PRODUCTION OF CGMP NATIVE FLEXIBLY LINKED HIV-1 ENVELOPE PROTEIN
$2,509,960Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI
Developmental Core
$2,508,540Paul A. Goepfert · University Of Alabama At Birmingham · P30 · FY2017 · AI
PS04-012, HIV PREVENTION PROJECTS
$2,508,313Jerry Burkman · Indiana State Department Of Health · U62 · FY2007 · PS
Novel Cord Blood-Derived Cellular Therapies
$2,508,224Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2019 · CA
Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development
$2,507,678Shaunna Shen · Duke University · N01 · FY2023 · AI
Environmental factors in placental pathology: a new diagnostic method based on umbilical vessel wave mechanics
$2,507,213John G Sled · Hospital For Sick Chldrn (Toronto) · U01 · FY2015 · HD
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice
$2,506,585Paul J Kenny · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · DA
Consumer Products and Therapeutics Research Program
$2,506,485Kyla Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Center for AIDS Research at Emory University
$2,506,289James W. Curran · Emory University · P30 · FY2013 · AI